It is estimated that 12% of Americans suffer from migraine headaches.
Research efforts over the past decade have resulted in several FDA-approved treatments. One of these research studies found the Calcitonin gene-related peptide (CGRP) antibodies are the most impactful. While these advancements have improved the lives of countless individuals, there remain many for whom currently available treatments remain inadequate.
For more than 30 years, MedVadis Research has been committed to finding new treatments for migraine sufferers. If you suffer from migraine, consider helping us find the next generation of migraine treatments.
If your current migraine treatments are not working well, then volunteering for a migraine research study at MedVadis Research can be a way to access new and possibly more effective treatment options. You will also get a thorough evaluation of your migraine headache condition and be under the care of some of Boston’s leading headache specialists. With your permission, our doctors will also provide your physician with treatment recommendations to help guide care of your migraine condition once the study has ended.
Please read our blog post on Transforming Migraine Treatment.
Healthcare insurance is not required and you may be reimbursed for your time.